软骨肉瘤相关基因Sox9(siRNA)表达质粒的构建鉴定以及对肿瘤细胞生长和凋亡的影响

秦宏敏, 韩会峰, 沙广钊, 刘林, 彭易根, 任天成

秦宏敏, 韩会峰, 沙广钊, 刘林, 彭易根, 任天成. 软骨肉瘤相关基因Sox9(siRNA)表达质粒的构建鉴定以及对肿瘤细胞生长和凋亡的影响[J]. 中国肿瘤临床, 2008, 35(3): 158-161.
引用本文: 秦宏敏, 韩会峰, 沙广钊, 刘林, 彭易根, 任天成. 软骨肉瘤相关基因Sox9(siRNA)表达质粒的构建鉴定以及对肿瘤细胞生长和凋亡的影响[J]. 中国肿瘤临床, 2008, 35(3): 158-161.
QIN Hong-min, HAN Hui-feng, SHA Guang-zhao, LIU Lin, PENG Yi-gen, REN Tian-cheng. Construction and Identification of a siRNA Expression Plasmid Targeting Sox9 and Its Effect on the Growth and Apoptosis of Human Chondrosarcoma Cells[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2008, 35(3): 158-161.
Citation: QIN Hong-min, HAN Hui-feng, SHA Guang-zhao, LIU Lin, PENG Yi-gen, REN Tian-cheng. Construction and Identification of a siRNA Expression Plasmid Targeting Sox9 and Its Effect on the Growth and Apoptosis of Human Chondrosarcoma Cells[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2008, 35(3): 158-161.

软骨肉瘤相关基因Sox9(siRNA)表达质粒的构建鉴定以及对肿瘤细胞生长和凋亡的影响

详细信息
    通讯作者:

    秦宏敏

  • 中图分类号: R738

Construction and Identification of a siRNA Expression Plasmid Targeting Sox9 and Its Effect on the Growth and Apoptosis of Human Chondrosarcoma Cells

  • 摘要: 目的: 利用小干扰阻断目的基因的原理将构建的目的基因Sox9的pSilencer3,1-H1 neo siRNA(small interfering RNA)表达质粒转染人体软骨肉瘤细胞HTB-94,观察目的基因被阻断后肿瘤细胞目的基因的表达、肿瘤细胞生长和凋亡所受到的影响。 方法: 设计并合成Sox9(siRNA),鉴定后将其转染HTB-94肿瘤细胞,观察肿瘤细胞的Sox9基因的mRNA和蛋白表达的变化,以及被转染肿瘤细胞的生长曲线和肿瘤细胞凋亡的情况。 结果: Sox9(siRNA)的插入片段测序结果与合成的siRNA结果一致,被转染的HTB-94Sox9基因的mRNA的表达量下降了35.4%,蛋白的表达量下降了31.3%;Sox9(siRNA)转染HTB-94细胞24h和96h的光吸收值分别为0.146±0.037和0.412±0.036,而正常对照细胞组两个同样时间段的光吸收值分别为0.152±0.0367和0.607±0.029。其中细胞生长增殖速度的差异为32.0%,肿瘤细胞的生长明显受到抑制;Sox9(siRNA)转染HTB-94细胞的干扰组细胞凋亡率为39.2%;而未经干扰的HTB-94肿瘤细胞的细胞凋亡率为0.1%。 结论: 经过设计合成的Sox9(siRNA)表达质粒可以稳定转染人体软骨肉瘤细胞HTB-94肿瘤细胞,被Sox9(siRNA)表达质粒转染的人体软骨肉瘤细胞HTB-94肿瘤细胞Sox9基因的mRNA和蛋白的表达都受到抑制,同时肿瘤细胞的生长繁殖也受到明显抑制,肿瘤细胞的凋亡明显增加。
    Abstract: Objective: To construct a siRNA expression plasmid targeting Sox9 and to investigate its effect on thegrowth and apoptosis of human chondrosarcoma cells. Methods: After designing and synthesizing the siRNA expressionplasmid, it was transfected into HTB-94 human chondrosarcoma cells and confirmed by enzyme digestion analysis andDNA sequencing. The expression of Sox9 mRNA and protein was assessed and cell growth and apoptosis were observed. Results: Compared with that of untransfected cells, the expression of Sox9 mRNA in transfected HTB-94 cells was re-duced by 35.4%, and the protein expression was reduced by 31.3%. The light absorbance values in transfected cells after24h and 96h were 0.146± 0.037 and 0.412± 0.036, but were 0.152± 0.0367 and 0.607± 0.029 in untransfected cells. Thecell growth in transfected cells was 32% lower than that in untransfected cells. The apoptosis rate was 39.2% in transfect-ed cells and 0.1% in untransfected cells. Conclusion: After transfection into HTB-94 human chondrosarcoma cells, asiRNA expression plasmid targeting Sox9 reduced mRNA and protein expression, inhibiting growth and causing apoptosisof the tumor cells.
  • [1] Furusawa T, Lim JH, Catez F, et al. Down-regulation of nucleo-somal binding protein HMGN1 expression during embryogenesismodulates Sox9 expression in chondrocytes [J]. Mol Cell Biol,2006, 26(2): 592~604
    [2] Shintani N, Kurth T, Hunziker EB. Expression of cartilage-relat-ed genes in bovine synovial tissue [J]. J Orthop Res, 2007, 25(6):813~819
    [3] 秦宏敏, 许 铁, 姚爱明, 等.Sox9 基因与软骨组织的研究进展 [J]. 中华实验外科杂志,2006,23(20):255~256
    [4] Cucchiarini M, Thurn T, Weimer A, et al. Restoration of theextracellular matrix in human osteoarthritic articular cartilage byoverexpression of the transcription factor SOX9 [J]. ArthritisRheum, 2007, 56(1): 158~167
    [5] Schaefer JF, Millham ML, de Crombrugghe B, et al. FGF signal-ing antagonizes cytokine-mediated repression of Sox9 in SW1353chondrosarcoma cells [J]. Osteoarthritis Cartilage, 2003, 11 (4):233~241
    [6] Soderstrom M, Bohling T, Ekfors T, et al. Molecular profiling ofhuman chondrosarcomas for matrix production and cancer mark-ers[J]. Int J Cancer, 2002, 100(2): 144~151
    [7] Wehrli BM, Huang W, De Crombrugghe B, et al. Sox9, a masterregulator of chondrogenesis, distinguishes mesenchymal chon-drosarcoma from other small blue round cell tumors [J]. HumPathol, 2003, 34(3): 263~269
    [8] Brummelkamp TR, Bernards R, Agami R. A system for stableexpression of short interfering RNAs in mammalian cells[J].Sci-ence, 2002, 296 (5567): 550~553
    [9] 彭广新, 李大鹏. 肿瘤干细胞与恶性肿瘤的靶向治疗 [J]. 中国肿瘤临床,2006,33(7):418~420
    [10] 张晓菁 温泽清 白爱民, 等. 载体表达小干扰 RNA 逆转卵巢癌的多药耐药 [J]. 中国肿瘤临床,2006,33(3):134~137
计量
  • 文章访问数:  5
  • HTML全文浏览量:  0
  • PDF下载量:  2
  • 被引次数: 0
出版历程
  • 收稿日期:  2007-08-05
  • 修回日期:  2007-10-21
  • 发布日期:  2008-02-14

目录

    /

    返回文章
    返回